BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Treatment
231 results:

  • 1. Assessing the relationship between tumor-infiltrating lymphocytes and PD-L1 expression in triple negative breast cancer: Identifying optimal TILs cut-off value for pathologic reporting.
    Suwannaphoom K; Soontornsit S; Wiwatwarayos K; Seneetuntigul P; Julimasart P
    Ann Diagn Pathol; 2024 Jun; 70():152294. PubMed ID: 38513466
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
    Lin CC; Chang TC; Wang Y; Guo L; Gao Y; Bikorimana E; Lemoff A; Fang YV; Zhang H; Zhang Y; Ye D; Soria-Bretones I; Servetto A; Lee KM; Luo X; Otto JJ; Akamatsu H; Napolitano F; Mani R; Cescon DW; Xu L; Xie Y; Mendell JT; Hanker AB; Arteaga CL
    Nat Commun; 2024 Mar; 15(1):2287. PubMed ID: 38480701
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary thyroid lymphoma: a case series.
    Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
    J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel bystander effect in tamoxifen treatment: PPIB derived from ER+ cells attenuates ER- cells via endoplasmic reticulum stress-induced apoptosis.
    Yang T; Li W; Zhou J; Xu M; Huang Z; Ming J; Huang T
    Cell Death Dis; 2024 Feb; 15(2):147. PubMed ID: 38360722
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises.
    Ahmad J; Ahamad J; Algahtani MS; Garg A; Shahzad N; Ahmad MZ; Imam SS
    Expert Opin Drug Deliv; 2024 Feb; 21(2):229-244. PubMed ID: 38344809
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Immunotherapy for non-small cell lung cancer.
    Kagamu H
    Respir Investig; 2024 Mar; 62(2):307-312. PubMed ID: 38310751
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long-term outcomes with HLX01 (HanliKang
    Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
    BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
    Huang F; Ruan Y; He X; Lian H; Yang J
    World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Artificial intelligence-assisted ultrasound-guided focused ultrasound therapy: a feasibility study.
    Sadeghi-Goughari M; Rajabzadeh H; Han JW; Kwon HJ
    Int J Hyperthermia; 2023; 40(1):2260127. PubMed ID: 37748776
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Novel MRI-guided focussed ultrasound stimulated microbubble radiation enhancement treatment for breast cancer.
    Dasgupta A; Saifuddin M; McNabb E; Ho L; Lu L; Vesprini D; Karam I; Soliman H; Chow E; Gandhi S; Trudeau M; Tran W; Curpen B; Stanisz G; Sahgal A; Kolios M; Czarnota GJ
    Sci Rep; 2023 Aug; 13(1):13566. PubMed ID: 37604988
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy.
    Wang Q; Sun K; Liu R; Song Y; Lv Y; Bi P; Yang F; Li S; Zhao J; Li X; Chen D; Mei J; Yang R; Chen K; Liu D; Tang S
    Clin Transl Med; 2023 Aug; 13(8):e1346. PubMed ID: 37525587
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Metformin combined with glucose starvation synergistically suppress triple-negative breast cancer by enhanced unfolded protein response.
    Li Y; Zhang Q; Yang J; He W; Jiang Y; Chen Y; Wang Y
    Biochem Biophys Res Commun; 2023 Oct; 675():146-154. PubMed ID: 37473529
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Induction of Unfolded Protein Response by Tannic Acid Triggers Apoptosis in MDA-MB-231 breast cancer Cells.
    Dehghani Champiri V; Abbasi Y; Karami H
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):2029-2035. PubMed ID: 37378933
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Solid tumor treatment via augmentation of bioactive C6 ceramide levels with thermally ablative focused ultrasound.
    Thim EA; Fox T; Deering T; Vass LR; Sheybani ND; Kester M; Price RJ
    Drug Deliv Transl Res; 2023 Dec; 13(12):3145-3153. PubMed ID: 37335416
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32).
    Hershman DL; Chen BE; Sathe C; Parulekar WR; Lemieux J; Ligibel JA; Gelmon KA; Whelan TJ; Goodwin PJ
    Breast Cancer Res Treat; 2023 Jul; 200(1):93-102. PubMed ID: 37157006
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The effectiveness of ultrasound-guided core needle biopsy in detecting lymph node metastases in the axilla in patients with breast cancer: systematic review and meta-analysis.
    Xu Q; Wang J; Wang J; Guo R; Qian Y; Liu F
    Clinics (Sao Paulo); 2023; 78():100207. PubMed ID: 37141768
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Successful Prevention of Tumour Lysis Syndrome in HER2-positive breast cancer: Case Report and Literature Review.
    Omori S; Shigechi T; Kawaguchi K; Ijichi H; Oki E; Yoshizumi T
    Anticancer Res; 2023 May; 43(5):2371-2377. PubMed ID: 37097695
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Primary breast B-cell non-Hodgkin’s lymphoma of the breast. Case Report and review of the literature.
    Santiago-Sanabria L; Garza-Arrieta J; Porras-Ibarra GD; Malfavón-Farias M
    Rev Colomb Obstet Ginecol; 2023 Mar; 74(1):53-67. PubMed ID: 37093942
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. treatment of mammary cancer with focused ultrasound: A pilot study in canine and feline patients.
    Antoniou A; Spanoudes K; Damianou C
    Ultrasonics; 2023 Jul; 132():106974. PubMed ID: 36917874
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Baicalein prevents capecitabine-induced heart damage in female Wistar rats and enhances its anticancer potential in MCF-7 breast cancer cells.
    Ibrahim HA; Abd El-Alim AEF; El-Hafeez MA; Metwally MMM; Khamis T; Galal AAA
    Life Sci; 2023 Apr; 319():121523. PubMed ID: 36842762
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.